ZDHHC9 and Miyoshi myopathy: Additionally, these two antigens, along with other MM-associated antigens, including Wilms tumor 1 (WT1), MM special antigen 1 (MMSA-1), and Dickkopf-1 (DKK1), have been developed as tumor vaccines and used in combination with DCs vaccination or other strategies for immune vaccination for MM patients (89–91).